– USA, PA – B. Braun of America Inc., a leader in smart infusion therapy and pain management, today announced the appointment of Dr. Dorothee Bartels (Ph.D., MSc) and Michael Reitermann to its Board of Directors.
About Dr. Dorothee Bartels
Dr. Dorothee Bartels is a global business and scientific leader with extensive experience using data analytics to improve healthcare outcomes. Dr. Bartels currently serves as CDO at Aetion, a global leader in healthcare analytics. Previously, she was global head of Real World Evidence and Digital Sciences at UCB Biosciences, and Clinical and Real World Data Strategy Lead at X, The Moonshot Factory within Alphabet (formerly Google X). Earlier in her career, Dr. Bartels was Corporate Head of Global Epidemiology at Boehringer Ingelheim and then CDSO in the company’s innovation lab, BI X. She maintains appointments as Associate Professor for Public Health and Epidemiology at Hannover Medical School, and Adjunct Professor for Epidemiology and Biostatistics at McGill University.
Dr. Bartels holds an MSc degree in Epidemiology from the Harvard School of Public Health and a PhD in Human Biology (Epidemiology) from Hannover Medical School.
About Michael Reitermann
Michael Reitermann is a global commercial and technology leader with a distinguished record of anticipating and responding to developing technologies and care models that have transformed the healthcare sector. Before he retired from Siemens Healthineers in 2019, Mr. Reitermann served as a member of the Managing Board, responsible for diagnostics, enterprise services, and global sales and service. Before the spin-off of Siemens Healthineers, he held multiple executive positions at Siemens including CEO of Siemens Healthcare Diagnostics, President of the North American commercial organization, and CEO of Molecular Imaging/Siemens Healthcare.
Mr. Reitermann received an MS in Industrial Engineering from the Technical University of Karlsruhe, and an MBA from the University of British Columbia. He holds board positions with several international healthcare companies.
About B. Braun
B. Braun Medical Inc. is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Our purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients—we’re uniquely positioned to help health systems succeed now and in the future. B. Braun is headquartered in Bethlehem, Pennsylvania, and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap, and CAPS. The company employs 8,500 people at over 30 locations across North America.
Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise philosophy, B. Braun continuously exchanges knowledge with customers, partners, and clinicians to address the critical issues of improving care and lowering costs.
For more information: https://www.bbraunusa.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
